Cargando…
Control of bleeding in surgical procedures: critical appraisal of HEMOPATCH (Sealing Hemostat)
The need for advanced hemostatic agents increases with the complexity of surgical procedures and use of anticoagulation and antiplatelet treatments. HEMOPATCH (Sealing Hemostat) is a novel, advanced hemostatic pad that is composed of a synthetic, protein-reactive monomer and a collagen backing. The...
Autores principales: | Lewis, Kevin Michael, Kuntze, Carl Erik, Gulle, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694675/ https://www.ncbi.nlm.nih.gov/pubmed/26730213 http://dx.doi.org/10.2147/MDER.S90591 |
Ejemplares similares
-
Effectiveness of Hemopatch® versus Surgicel® Original to control mild and moderate liver bleeding
por: Uranues, Selman, et al.
Publicado: (2022) -
Real-World Data on the Usage of Hemopatch® as a Hemostat and Dural Sealant in Cranial and Spinal Neurosurgery
por: Schebesch, Karl-Michael, et al.
Publicado: (2023) -
Hemopatch(®) as a Hemostatic Agent is Safe in Partial Nephrectomy: A Large, Single-Surgeon Retrospective Evaluation
por: Hupe, Marie C., et al.
Publicado: (2020) -
Clinical Experience with Hemopatch® as a Dural Sealant in Cranial Neurosurgery
por: Schebesch, Karl-Michael, et al.
Publicado: (2019) -
Polyethylene glycol-coated collagen patch (hemopatch(®)) in open partial nephrectomy
por: Staehler, Michael, et al.
Publicado: (2021)